You deserve tomorrow.

US Leadership

John Ross

President, Mayne Pharma USA

Mr. Ross has more than 20 years’ experience in the pharmaceutical industry across marketing and sales, manufacturing and distribution, global sourcing and supply chain. Prior to joining Mayne Pharma, Mr. Ross was a Principal at Tunnell Consulting a leading US biotech and pharmaceutical consulting organization. He has also held a number of leadership roles including Chief Operating Officer of Contract Pharmaceuticals Limited, a provider of outsourced third-party contract development, manufacturing and testing of pharmaceuticals. 

 

Eric Evans

Chief Financial Officer, Mayne Pharma USA

Mr. Evans has 30 years of experience in financial leadership roles across both the pharmaceutical and contract services sectors. He was previously the CFO of AAIPharma Services, a leading global provider of contract services with over 800 employees across seven sites in the US and Europe. Prior to AAIPharma, he was CFO and EVP at Patheon, Inc. and VP and controller for Novartis Pharmaceuticals US branded business with sales in excess of US$8 billion. He was also CFO for Sandoz US, one of the world’s largest generic pharma companies. 

Craig Boyd

Executive Vice President, US Specialty Brands

Mr. Boyd has more than 20 years of experience in the pharmaceutical industry across generic, branded, biosimilar and device businesses and has worked extensively in the US, Europe and Australia. Prior to joining Mayne Pharma he was the head of sales for Pfizer’s US generic injectables division with revenue of over US$4 billion and more than 300 staff. Mr. Boyd was also previously the Vice President of Global Sales at Mylan leading sales teams across all international markets. He also spent 10 years in a number of senior commercial and sales and marketing roles at Novartis.

 

Gadi Ben-Nissim

Executive Vice President, US Generic Products

Mr. Ben-Nissim has spent the last 18 years at Teva in both regional and international roles across generics and specialty brands. In his last role at Teva he led the cross functional integration of the Actavis generics transaction in North America. His breadth of experience covers business unit leadership, commercial operations, marketing, portfolio management, product licensing, business strategy and M&A. Mr. Ben-Nissim holds a Bachelor of Science in Industrial Engineering from Technion in Israel and a MBA from Inter Disciplinary Institution (IDC) in Israel.

  

Kimberly McClintock

Executive Vice President, Metrics Contract Services

Ms. McClintock has more than 18 years of experience in the pharmaceutical industry across sales, business development, project management and research and development. Prior to joining Mayne Pharma, Kim led the Drug Product and Lab Services Business Unit as Senior Director at Alcami Corp, a leading global provider of contract development and manufacturing services. She also held several management roles at Banner Pharmacaps (division of Patheon). Ms. McClintock holds a Bachelor of Arts in Chemistry from North Carolina State University and a MBA from the University of North Carolina.